26Apr 2025
Succinate and SUCNR1 Antagonism Show Potential for IPF Therapy

Succinate and SUCNR1 Antagonism Show Potential for IPF Therapy

The study demonstrated that succinate and its receptor, SUCNR1, promote fibrosis in IPF by increasing fibrotic markers and exacerbating fibroblast-myofibroblast transition. In vitro, succinate treatment elevated collagen and α-SMA expression in IPF fibroblasts. In vivo, succinate worsened lung fibrosis and weight loss in bleomycin-treated mice. Targeting SUCNR1 could offer a new therapeutic approach for managing IPF.

  • #pulmonology

Like

Save

Share